Trials / Completed
CompletedNCT00474708
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
The Efficacy of Venlafaxine XR (Efexor XR®) Versus SSRIs & Conventional Antidepressants in Depressed Patients Switched From Prior Antidepressants in Psychiatric Outpatient Care Settings in China
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,151 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, randomized, multi-center study conducted in a typical psychiatric outpatient practice in China. This study is intended to collect data on the efficacy and safety of venlafaxine XR (Efexor XR®) versus SSRIs and conventional antidepressants in depressed patients that previously failed antidepressant treatment. This data will be used to guide psychiatrists on recommendations for clinic use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effexor | |
| DRUG | SSRI |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2007-05-17
- Last updated
- 2012-03-05
- Results posted
- 2010-04-30
Locations
26 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00474708. Inclusion in this directory is not an endorsement.